Antibiotic Stewardship (ABS). Teil 2: Anwendung

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • S. Wendt - , Universität Leipzig (Autor:in)
  • D. Ranft - , Universität Leipzig (Autor:in)
  • K. de With - , Klinische Infektiologie, Universitätsklinikum Carl Gustav Carus Dresden (Autor:in)
  • W. V. Kern - , Albert-Ludwigs-Universität Freiburg (Autor:in)
  • B. Salzberger - , Universität Regensburg (Autor:in)
  • C. Lübbert - , Universität Leipzig (Autor:in)

Abstract

Antibiotic stewardship (ABS) is an important measure to counteract the spread of resistant pathogens and multidrug resistance. The most important ABS tools include the implementation of local guidelines, the development of a house-related list of anti-infective agents, regular ABS visits and practice-oriented internal training events. Effective strategies for therapy optimization include indication testing and therapy evaluation, dose optimization as well as determining an appropriate duration of therapy. Oralization of anti-infectives (sequence therapy) should be supported by consistent clinical criteria in in-house guidelines. The incidence of Clostridioides difficile infections (CDI) can be more than halved by restricting the so-called “4C antibiotics”. Point-of-care tests help to minimize the use of antibiotics in the outpatient setting. Vaccination reduces the need for antibiotic therapy.

Details

OriginalspracheDeutsch
Seiten (von - bis)475-486
Seitenumfang12
FachzeitschriftDer Internist
Jahrgang61
Ausgabenummer5
PublikationsstatusVeröffentlicht - 1 Mai 2020
Peer-Review-StatusJa

Externe IDs

PubMed 32112153
ORCID /0000-0001-9473-3018/work/148606208

Schlagworte

Ziele für nachhaltige Entwicklung

ASJC Scopus Sachgebiete

Schlagwörter

  • Anti-bacterial agents, Antimicrobial stewardship, Clostridioides difficile, Guidelines, local, Vaccination